© 1995 American Heart Association, Inc.
Articles |
Effects of Iron- and Hemoglobin-Loaded Human Monocyte–Derived Macrophages on Oxidation and Uptake of LDL
From the Departments of Internal Medicine and Pathology II, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
Correspondence to Dr Xi Ming Yuan, Clinical Research Center, Faculty of Health Sciences, Linköping University, S-582 25 Linköping, Sweden.
Abstract It is generally accepted that transition metals are required for cellular LDL oxidation. LDL may also be oxidized by iron and reducing agents in cell-free systems. We hypothesized that lysosomal iron may be exocytosed from macrophages that have been iron loaded by phagocytosis and degradation of iron-rich structures, eg, erythrocytes, and that such released iron may promote LDL oxidation and uptake by macrophages. Human monocyte–derived macrophages (HMDMs) were isolated and cultured for 7 days and then exposed to FeCl3, Fe-ADP, or Fe-EDTA (100 µmol/L) or hemoglobin (25 or 50 µg/mL) for 24 hours. After rinsing, LDL (50 to 150 µg/mL) was added in fresh culture medium without serum. After another 24 hours the media concentrations of iron and thiobarbituric acid–reacting substances as well as the electrophoretic mobility of LDL were increased, while the cells showed only minimal signs of decreased viability. Lipofuscin, neutral lipids, and phospholipids accumulated in a granular, lysosome-like pattern, and the cells acquired a foam cell–like morphology. There was a strong correlation (r=.87, P=.005) between the amount of iron added during the pre-exposure period and lipofuscin accumulation during the ensuing exposure to LDL in fresh, serum-free medium. Our results support our hypothesis and indicate that lysosomal iron may be exocytosed from HMDMs and promote oxidation and uptake of LDL and thus induce foam cell formation.
Key Words: LDL • foam cells • iron • exocytosis • oxygen radicals
This article has been cited by other articles:
 |
|
 |
|
  K. Yunoki, T. Naruko, R. Komatsu, S. Ehara, N. Shirai, K. Sugioka, M. Nakagawa, C. Kitabayashi, Y. Ikura, A. Itoh, et al. Enhanced expression of haemoglobin scavenger receptor in accumulated macrophages of culprit lesions in acute coronary syndromes Eur. Heart J., August 1, 2009; 30(15): 1844 - 1852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Schrijvers, G. R.Y. De Meyer, A. G. Herman, and W. Martinet Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability Cardiovasc Res, February 1, 2007; 73(3): 470 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Li, M. Ostblom, L.-H. Xu, A. Hellsten, P. Leanderson, B. Liedberg, U. T. Brunk, J. W. Eaton, and X.-M. Yuan Cytocidal effects of atheromatous plaque components: the death zone revisited FASEB J, November 1, 2006; 20(13): 2281 - 2290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Wolff, H. Volzke, J. Ludemann, D. Robinson, D. Vogelgesang, A. Staudt, C. Kessler, J. B. Dahm, U. John, and S. B. Felix Association Between High Serum Ferritin Levels and Carotid Atherosclerosis in the Study of Health in Pomerania (SHIP) Stroke, February 1, 2004; 35(2): 453 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. D. Kolodgie, H. K. Gold, A. P. Burke, D. R. Fowler, H. S. Kruth, D. K. Weber, A. Farb, L.J. Guerrero, M. Hayase, R. Kutys, et al. Intraplaque Hemorrhage and Progression of Coronary Atheroma N. Engl. J. Med., December 11, 2003; 349(24): 2316 - 2325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L Derstine, L. E Murray-Kolb, S. Yu-Poth, R. L Hargrove, P. M Kris-Etherton, and J. L Beard Iron status in association with cardiovascular disease risk in 3 controlled feeding studies Am. J. Clinical Nutrition, January 1, 2003; 77(1): 56 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Rossi, B. M. McQuillan, J. Hung, P. L. Thompson, C. Kuek, and J. P. Beilby Serum Ferritin and C282Y Mutation of the Hemochromatosis Gene as Predictors of Asymptomatic Carotid Atherosclerosis in a Community Population Stroke, December 1, 2000; 31(12): 3015 - 3020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M Cromheeke, M. M Kockx, G. R.Y De Meyer, J. M Bosmans, H. Bult, W. J.F Beelaerts, C. J Vrints, and A. G Herman Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques Cardiovasc Res, August 15, 1999; 43(3): 744 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. de Valk and J. J. M. Marx Iron, Atherosclerosis, and Ischemic Heart Disease Arch Intern Med, July 26, 1999; 159(14): 1542 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-S. Lee, M.-S. Shiao, C.-C. Pan, and L.-Y. Chau Iron-Deficient Diet Reduces Atherosclerotic Lesions in ApoE-Deficient Mice Circulation, March 9, 1999; 99(9): 1222 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Camejo, C. Halberg, A. Manschik-Lundin, E. Hurt-Camejo, B. Rosengren, H. Olsson, G. I. Hansson, G.-B. Forsberg, and B. Ylhen Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages J. Lipid Res., April 1, 1998; 39(4): 755 - 766. [Abstract] [Full Text]
|
|
|
|
|
|
S. Kiechl, J. Willeit, G. Egger, W. Poewe, F. Oberhollenzer, and f. t. B. S. Group Body Iron Stores and the Risk of Carotid Atherosclerosis : Prospective Results From the Bruneck Study Circulation, November 18, 1997; 96(10): 3300 - 3307. [Abstract] [Full Text]
|
|